• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相关五环三萜类化合物在慢性内脏利什曼病的实验中有免疫调节活性。

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.

机构信息

Laboratory of Pathology of Infectious Diseases (LIM50), Department of Pathology, Medical School of São Paulo University, Av. Dr. Arnaldo, 455 Cerqueira César, São Paulo, 01246-903 SP, Brazil.

Laboratório de Patologia Clínica, Departamento de Patologia, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

J Immunol Res. 2021 Feb 17;2021:6671287. doi: 10.1155/2021/6671287. eCollection 2021.

DOI:10.1155/2021/6671287
PMID:33681389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906800/
Abstract

Leishmaniasis is a neglected tropical disease caused by the flagellated protozoa of the genus that affects millions of people around the world. Drugs employed in the treatment of leishmaniasis have limited efficacy and induce local and systemic side effects to the patients. Natural products are an interesting alternative to treat leishmaniasis, because some purified molecules are selective toward parasites and not to the host cells. Thus, the aim of the present study was to compare the antileishmanial activity of the triterpenes betulin (Be), lupeol (Lu), and ursolic acid (UA); analyze the physiology and morphology of affected organelles; analyze the toxicity of selected triterpenes in golden hamsters; and study the therapeutic activity of triterpenes in hamsters infected with () as well as the cellular immunity induced by studied molecules. The triterpenes Lu and UA were active on promastigote (IC = 4.0 ± 0.3 and 8.0 ± 0.2 M, respectively) and amastigote forms (IC = 17.5 ± 0.4 and 3.0 ± 0.2 M, respectively) of () , and their selectivity indexes (SI) toward amastigote forms were higher (≥13.4 and 14, respectively) than SI of miltefosine (2.7). () promastigotes treated with Lu and UA showed cytoplasmic degradation, and in some of these areas, cell debris were identified, resembling autophagic vacuoles, and parasite mitochondria were swelled, fragmented, and displayed membrane potential altered over time. Parasite cell membrane was not affected by studied triterpenes. Studies of toxicity in golden hamster showed that Lu did not alter blood biochemical parameters associated with liver and kidney functions; however, a slight increase of aspartate aminotransferase level in animals treated with 2.5 mg/kg of UA was detected. Lu and UA triterpenes eliminated amastigote forms in the spleen (87.5 and 95.9% of reduction, respectively) and liver of infected hamster (95.9 and 99.7% of reduction, respectively); and UA showed similar activity at eliminating amastigote forms in the spleen and liver than amphotericin B (99.2 and 99.8% of reduction). The therapeutic activity of both triterpenes was associated with the elevation of IFN- and/or iNOS expression in infected treated animals. This is the first comparative work showing the activity, toxicity, and therapeutic activity of Lu and UA in the chronic model of visceral leishmaniasis caused by () ; additionally, both triterpenes activated cellular immune response in the hamster model of visceral leishmaniasis.

摘要

利什曼病是一种被忽视的热带病,由鞭毛原生动物引起,影响全球数百万人。用于治疗利什曼病的药物疗效有限,并会引起患者的局部和全身副作用。天然产物是治疗利什曼病的一个有趣选择,因为一些纯化的分子对寄生虫具有选择性,而不对宿主细胞具有选择性。因此,本研究的目的是比较桦木醇(Be)、羽扇豆醇(Lu)和熊果酸(UA)这三种三萜类化合物的抗利什曼原虫活性;分析受影响的细胞器的生理学和形态;分析所选三萜类化合物在金黄地鼠中的毒性;并研究三萜类化合物在感染 () 的金黄地鼠中的治疗活性以及研究分子诱导的细胞免疫。三萜类化合物 Lu 和 UA 对 () 的前鞭毛体(IC = 4.0 ± 0.3 和 8.0 ± 0.2 μM,分别)和无鞭毛体形式(IC = 17.5 ± 0.4 和 3.0 ± 0.2 μM,分别)具有活性,它们对无鞭毛体形式的选择性指数(SI)高于米替福新(2.7)。Lu 和 UA 处理的 () 前鞭毛体表现出细胞质降解,在这些区域中的某些区域中,鉴定到细胞碎片,类似于自噬空泡,并且寄生虫线粒体肿胀、碎片化,并且随着时间的推移显示出改变的膜电位。研究的三萜类化合物未影响寄生虫细胞膜。在金黄地鼠中的毒性研究表明,Lu 不会改变与肝功能和肾功能相关的血液生化参数;然而,在 2.5 mg/kg 的 UA 处理的动物中检测到天门冬氨酸氨基转移酶水平略有升高。Lu 和 UA 三萜类化合物消除了感染金黄地鼠脾脏(减少 87.5%和 95.9%)和肝脏(减少 95.9%和 99.7%)中的无鞭毛体形式;并且 UA 在消除脾脏和肝脏中的无鞭毛体形式方面与两性霉素 B 具有相似的活性(减少 99.2%和 99.8%)。两种三萜类化合物的治疗活性均与感染后治疗动物中 IFN-和/或 iNOS 表达的升高有关。这是首次比较研究表明 Lu 和 UA 在 () 引起的内脏利什曼病慢性模型中的活性、毒性和治疗活性;此外,两种三萜类化合物均在内脏利什曼病金黄地鼠模型中激活了细胞免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/db0d47bed518/JIR2021-6671287.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/97ee264e090f/JIR2021-6671287.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/76cf1fb4f962/JIR2021-6671287.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/58fabf5fdc56/JIR2021-6671287.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/5155ded46dd4/JIR2021-6671287.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/9080f1f86fa8/JIR2021-6671287.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/44499260efa1/JIR2021-6671287.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/db0d47bed518/JIR2021-6671287.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/97ee264e090f/JIR2021-6671287.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/76cf1fb4f962/JIR2021-6671287.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/58fabf5fdc56/JIR2021-6671287.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/5155ded46dd4/JIR2021-6671287.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/9080f1f86fa8/JIR2021-6671287.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/44499260efa1/JIR2021-6671287.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/7906800/db0d47bed518/JIR2021-6671287.009.jpg

相似文献

1
Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.相关五环三萜类化合物在慢性内脏利什曼病的实验中有免疫调节活性。
J Immunol Res. 2021 Feb 17;2021:6671287. doi: 10.1155/2021/6671287. eCollection 2021.
2
Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.从猪殃殃中分离得到的三萜化合物羽扇醇具有抗利什曼原虫和免疫调节活性。
Int J Antimicrob Agents. 2017 Oct;50(4):512-522. doi: 10.1016/j.ijantimicag.2017.04.022. Epub 2017 Jun 29.
3
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis.熊果酸对实验性内脏利什曼病的治疗作用。
Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):1-11. doi: 10.1016/j.ijpddr.2016.12.002. Epub 2016 Dec 8.
4
Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.羽扇豆醇和两性霉素B对杜氏利什曼原虫感染的BALB/c小鼠具有协同抗利什曼原虫免疫调节作用。
Cytokine. 2021 Jan;137:155319. doi: 10.1016/j.cyto.2020.155319. Epub 2020 Sep 29.
5
Eugenol derived immunomodulatory molecules against visceral leishmaniasis.源于丁香酚的免疫调节分子对抗内脏利什曼病。
Eur J Med Chem. 2017 Oct 20;139:503-518. doi: 10.1016/j.ejmech.2017.08.030. Epub 2017 Aug 12.
6
15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.15d-前列腺素J2在实验性内脏利什曼病期间诱导活性氧介导的细胞凋亡。
J Mol Med (Berl). 2016 Jun;94(6):695-710. doi: 10.1007/s00109-016-1384-5. Epub 2016 Feb 1.
7
Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.评估熊果酸作为治疗皮肤利什曼病和内脏利什曼病的生物制品的潜力。
Molecules. 2020 Mar 19;25(6):1394. doi: 10.3390/molecules25061394.
8
β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.β-氨基酸衍生物作为 L. donovani 的线粒体复合物 III 抑制剂:一种有前途的针对内脏利什曼病的化学型。
Eur J Med Chem. 2019 Nov 15;182:111632. doi: 10.1016/j.ejmech.2019.111632. Epub 2019 Aug 20.
9
In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.感染利什曼原虫的仓鼠经呋喃叉衍生物治疗后的体内抗利什曼原虫活性和组织病理学评价。
Biomed Pharmacother. 2017 Nov;95:536-547. doi: 10.1016/j.biopha.2017.08.096. Epub 2017 Sep 12.
10
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.伊维菌素在体外和体内对利什曼原虫具有有效和选择性的抗利什曼活性,并具有治疗内脏利什曼病的作用。
Exp Parasitol. 2021 Feb;221:108059. doi: 10.1016/j.exppara.2020.108059. Epub 2020 Dec 16.

引用本文的文献

1
Anti- Activity of Morolic Acid, a Pentacyclic Triterpene with Effects on Innate Immune Response during Macrophage Infection.齐墩果酸的抗活性,一种五环三萜,对巨噬细胞感染期间的天然免疫反应有影响。
Microorganisms. 2024 Jul 9;12(7):1392. doi: 10.3390/microorganisms12071392.
2
Nanostructured Lipid Carriers as Robust Systems for Lupeol Delivery in the Treatment of Experimental Visceral Leishmaniasis.纳米结构脂质载体作为用于齐墩果醇递送以治疗实验性内脏利什曼病的强大系统。
Pharmaceuticals (Basel). 2023 Nov 23;16(12):1646. doi: 10.3390/ph16121646.
3
Exploring the leishmanicidal potential of terpenoids: a comprehensive review on mechanisms of cell death.

本文引用的文献

1
Antileishmanial and antitrypanosomal drug identification.抗利什曼原虫和抗锥虫药物鉴定。
Emerg Top Life Sci. 2017 Dec 22;1(6):613-620. doi: 10.1042/ETLS20170103.
2
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis.熊果酸增强实验性利什曼病的传统治疗效果。
Pathogens. 2020 Oct 20;9(10):855. doi: 10.3390/pathogens9100855.
3
Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model.熊果酸:基于 PK-PD 模型的药理学、毒性的系统评价及其药代动力学再思考。
探索萜类化合物的杀利什曼原虫潜力:细胞死亡机制的综合综述。
Front Cell Infect Microbiol. 2023 Sep 19;13:1260448. doi: 10.3389/fcimb.2023.1260448. eCollection 2023.
4
The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.传统知识在开发治疗利什曼病有效药物方面的潜力。
Front Pharmacol. 2021 Jun 8;12:690432. doi: 10.3389/fphar.2021.690432. eCollection 2021.
5
Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from .从……中分离出的齐墩果酸的杀利什曼原虫活性及超微结构变化
Evid Based Complement Alternat Med. 2021 May 31;2021:9970983. doi: 10.1155/2021/9970983. eCollection 2021.
Fitoterapia. 2020 Nov;147:104735. doi: 10.1016/j.fitote.2020.104735. Epub 2020 Sep 30.
4
Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.妥萘酯抑制麦角固醇的产生并影响利什曼原虫的细胞活力。
Bioorg Chem. 2020 Sep;102:104056. doi: 10.1016/j.bioorg.2020.104056. Epub 2020 Jul 2.
5
Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.评估熊果酸作为治疗皮肤利什曼病和内脏利什曼病的生物制品的潜力。
Molecules. 2020 Mar 19;25(6):1394. doi: 10.3390/molecules25061394.
6
High Dietary Kuding Tea Extract Supplementation Induces Hepatic Xenobiotic-Metabolizing Enzymes-A 6-Week Feeding Study in Mice.高剂量苦丁茶提取物补充物诱导肝脏外源性物质代谢酶:一项为期 6 周的小鼠喂养研究。
Nutrients. 2019 Dec 22;12(1):40. doi: 10.3390/nu12010040.
7
Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis.羽扇豆醇可诱导小鼠对内脏利什曼病产生免疫和保护效力。
Parasitology. 2019 Sep;146(11):1440-1450. doi: 10.1017/S0031182019000659. Epub 2019 Jun 13.
8
New lupeol esters as active substances in the treatment of skin damage.新型羽扇豆醇酯类化合物作为治疗皮肤损伤的活性物质。
PLoS One. 2019 Mar 28;14(3):e0214216. doi: 10.1371/journal.pone.0214216. eCollection 2019.
9
Activity of Fenticonazole, Tioconazole and Nystatin on New World Leishmania Species.芬替康唑、噻康唑和制霉菌素对新世界利什曼原虫的活性。
Curr Top Med Chem. 2018;18(27):2338-2346. doi: 10.2174/1568026619666181220114627.
10
Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.内脏利什曼病患者的疾病严重程度不会因同时感染肠道寄生虫而改变。
PLoS Negl Trop Dis. 2017 Jul 21;11(7):e0005727. doi: 10.1371/journal.pntd.0005727. eCollection 2017 Jul.